Takahiro Kambara
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Reply to "Correspondence: SPARC, HEG1, and the Diagnosis of Epithelioid Mesothelioma" by Churg et al.
Journal: The American journal of surgical pathology
Published: February 15, 2024
Musashi-1 Is a Novel Immunohistochemical Marker of Neuroendocrine Carcinoma of the Lung.
Journal: Cancers
Published: November 13, 2023
SPARC Is a Novel Positive Immunohistochemical Marker of Epithelioid Mesothelioma to Differentiate It From Lung Adenocarcinoma and/or Squamous Cell Carcinoma.
Journal: The American journal of surgical pathology
Published: October 30, 2023
Laparoscopic excision of a retroperitoneal pseudocyst using a modified medial approach: A case report.
Journal: International journal of surgery case reports
Published: August 13, 2023
FOXM1 Promotes Mesothelioma Cell Migration and Invasion via Activation of SMAD Signaling.
Journal: Anticancer research
Published: June 07, 2023
Insulin-Like Growth Factor 2 mRNA Binding Protein 3 Promotes Cell Proliferation of Malignant Mesothelioma Cells by Downregulating p27Kip1.
Journal: Frontiers in oncology
Published: October 15, 2021
Primary Pulmonary Mucosa-associated Lymphoid Tissue Lymphoma with the High Expression of IgG4.
Journal: Internal medicine (Tokyo, Japan)
Published: September 21, 2021
Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung.
Journal: Translational lung cancer research
Published: March 15, 2021
Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer.
Journal: BMC pulmonary medicine
Published: January 15, 2021
Last Updated: 09/26/2026